Drug Profile
Research programme: vitamin D3 analogues - Teijin
Alternative Names: TEI-K04887Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Teijin Pharma
- Class Vitamin D analogues
- Mechanism of Action Calcitonin receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Secondary hyperparathyroidism
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Secondary-hyperparathyroidism in Japan
- 15 Sep 2009 Preclinical trials in Secondary hyperparathyroidism in Japan (unspecified route)